Why the study?
Can a percutaneous valve-in-valve procedure using the Corevalve Revalving system successfully treat severe regurgitation of a degenerated aortic bioprosthesis?
Can a percutaneous valve-in-valve procedure using the Corevalve Revalving system successfully treat severe regurgitation of a degenerated aortic bioprosthesis?
This case report demonstrates the initial feasibility of a percutaneous valve-in-valve procedure using the Corevalve Revalving system for treating severe regurgitation in a degenerated bioprosthesis.
May offer less invasive option for high-risk patients with degenerated bioprostheses; leaves open durability and generalizability.
Percutaneous valve replacement for severe aortic stenosis has shown to be an alternative treatment option for non-surgical candidates. We report on the first successful valve in valve procedure in an 80-year-old patient with a severe regurgitation of a degenerated aortic bioprosthesis using the Corevalve Revalving system.
No takes yet. Share an insight, caveat, or question.
Wenaweser et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: